Germany to launch cannabis farming as Canada’s Aurora, Aphria win tenders

FRANKFURT (Reuters) – Germany has awarded contracts to supply domestically-grown cannabis to two Canadian companies, as it seeks to develop its own medicinal marijuana industry and reduce reliance on imports.

Drugs regulator BfArM said on Wednesday it would purchase 4,000 kg and 3,200 kg of cannabis over four years from German production subsidiaries of Canada’s Aurora Cannabis and Aphria, respectively.

Another tender over a four-year harvest of 3200 kg has been delayed because an unidentified bidder who lost out is challenging the procedure with a regulator.

The first home-grown harvest is slated for late 2020, the German drugs watchdog said in its statement, describing the tender as an “important step for the supply of medical-grade cannabis grown in Germany to critically ill patients”.

Aurora shares rose on April 5, when the company announced it was one of the winners in the German production tender, citing preliminary results.

Germany has depended on imports of medical cannabis, mainly from Canada and the Netherlands. No new hurdles on imports will be introduced with the launch of cannabis farming in Germany.

A growing number of countries have legalized or are in the…

Continue reading at Reuters.com

About Reuters

Since 1850, we have experimented, invented, and created content and news solutions to become the world’s leading international news agency. Always at the forefront of real-time breaking news and high-impact global multimedia content, we are constantly innovating our products and services to meet your business needs. Whether we are serving broadcasters, publishers, brands, agencies, or direct to consumers, Reuters provides award-winning coverage of the day’s most important topics, including: business, finance, politics, sports, entertainment, technology, health, environment, and much more.